Literature DB >> 17237930

[Significance of parotid metastases of squamous cell carcinoma of scalp].

A Teymoortash1, E S Schultz, J A Werner.   

Abstract

BACKGROUND: The aim of the study was the characterization of patients with metastatic cutaneous squamous cell carcinoma involving the parotid gland. PATIENTS AND METHODS: The clinical, radiological and pathological tumor data of 16 patients with parotid metastasis of a previously treated squamous cell carcinoma of the skin were analyzed retrospectively.
RESULTS: Patients over 70 years of age with a primary skin cancer of at least 1.5 centimeter in diameter were defined as the high risk group for development of regional metastasis involving the parotid gland. The time interval between therapy of the skin cancer and detection of the metastatic involvement of the parotid gland was 9.8 (2-24) months on average. The average maximal diameter of the parotid metastasis was 3.2 (1.5-4.9) centimeter at diagnosis. Metastatic infiltration of cervical lymph nodes could be shown in 9 patients and in 2 patients pulmonary metastases were detected. The average survival after parotid metastasis was 11.7 (3-31) months.
CONCLUSION: The early diagnosis and therapy of locoregional metastasis from cutaneous squamous cell carcinoma of the scalp have a high prognostic value. High-risk patients with cutaneous squamous cell carcinoma should be followed up sonographically in narrow intervals for detection of parotid and cervical lymph node metastasis.

Entities:  

Mesh:

Year:  2007        PMID: 17237930     DOI: 10.1007/s00105-006-1275-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  28 in total

1.  Microstaging of squamous cell carcinomas.

Authors:  H Breuninger; B Black; G Rassner
Journal:  Am J Clin Pathol       Date:  1990-11       Impact factor: 2.493

2.  The frequency and risk of metastases in squamous-cell carcinoma of the skin.

Authors:  A D KATZ; F URBACH; A M LILIENFELD
Journal:  Cancer       Date:  1957 Nov-Dec       Impact factor: 6.860

3.  Parotid area lymph node metastases from cutaneous squamous cell carcinoma: implications for diagnosis, treatment, and prognosis.

Authors:  Theodore S Hong; Kevin J Kriesel; Gregory K Hartig; Paul M Harari
Journal:  Head Neck       Date:  2005-10       Impact factor: 3.147

4.  Immunosuppression in patients with metastatic squamous cell carcinoma from the skin.

Authors:  S M Dinehart; D Z Chu; A W Maners; S V Pollack
Journal:  J Dermatol Surg Oncol       Date:  1990-03

5.  Metastatic patterns of squamous carcinoma in the parotid lymph nodes.

Authors:  K Lee; M E McKean; I A McGregor
Journal:  Br J Plast Surg       Date:  1985-01

Review 6.  Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection.

Authors:  D E Rowe; R J Carroll; C L Day
Journal:  J Am Acad Dermatol       Date:  1992-06       Impact factor: 11.527

7.  Metastatic tumours of the parotid region.

Authors:  P J Bergersen; P J Kennedy; K L Kneale
Journal:  Aust N Z J Surg       Date:  1987-01

8.  Malignant neoplastic disease of the parotid lymph nodes.

Authors:  W A Schroeder; W D Stahr
Journal:  Laryngoscope       Date:  1998-10       Impact factor: 3.325

9.  Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma.

Authors:  Carsten E Palme; Christopher J O'Brien; Michael J Veness; Edward B McNeil; Luc P Bron; Gary J Morgan
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-07

10.  Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome.

Authors:  Eddy Dona; Michael J Veness; Burcu Cakir; Gary J Morgan
Journal:  ANZ J Surg       Date:  2003-09       Impact factor: 1.872

View more
  1 in total

1.  Current advances in diagnosis and surgical treatment of lymph node metastasis in head and neck cancer.

Authors:  A Teymoortash; J A Werner
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.